Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ivor Royston currently holds 50,438 shares of Viracta Therapeutics, Inc. (VIRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ivor Royston has been a net buyer of VIRX stock. They have purchased $8.2M and sold $119.3K worth of shares.
Ivor Royston's most recent insider trade was on Nov 25, 2024, when they sold 25,219 shares at $0.00 per share.
Ivor Royston serves as Executive at Viracta Therapeutics, Inc. (VIRX). They have executed 52 insider transactions totaling $8.3M over their tenure at the company.
Ivor Royston holds the position of Executive at Viracta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Ivor Royston has shown a buying trading pattern, with $8.2M in total purchases and $119.3K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ivor Royston was on Mar 7, 2006, when they purchased $6.0M worth of FVRL shares. This transaction involved 1,140,684 shares at $5.26 per share.
Ivor Royston currently owns 50,438 shares of Viracta Therapeutics, Inc. (VIRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ivor Royston's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ivor Royston has 52 Form 4 filings on record as an insider at Viracta Therapeutics, Inc..
Set alerts for Ivor Royston and 40,000+ other insiders.